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ABSTRACT
Objective: The present study was aimed to assess the prevalence of complications and to assess the targets achieved during the management of 
diabetes mellitus type 2.
Methods: The study was prospective and conducted out in a diabetes center, Chennai, ethical approval was obtained from the Institutional Ethics 
Committee, case records of the 300 patients diagnosed with type 2 diabetes mellitus and its complications were monitored during March 2017–April 
2018. Major result actions are body weight, height, body mass index (BMI), blood pressure, fasting blood sugar (FBS), post-prandial blood sugar 
(PPBS) levels, glycosylated hemoglobin, serum lipids, and presence of complications of diabetes. Comparison of the average of various biochemical 
parameters was made in patients with and no diabetic complications.
Results: The average age of 300 patients was found to be 55.006±13.04. The average BMI was 27.10±12.81 kg/m2. The average duration of diabetes 
was 10.48±7.53. The average of systolic (SBP) and diastolic blood pressure was 137±20.88 and 79.95±11.81. The mean glycated hemoglobin, FBS, 
PPBS, low-density lipoprotein, high-density lipoprotein, and triglyceride, and total cholesterol were found to be 8.5±3.99, 148.85±55.64 mg/dl, 
200.98±72.63 mg/dl, 88.06±19.46 mg/dl, 36.20±8.27 mg/dl, 141.22±60.15 mg/dl, and 144.45±29.03 mg/dl, respectively. Among the microvascular 
complications; neuropathy, nephropathy, and retinopathy were documented in 8.33%, 23.66%, and 17.33% of patients, respectively. The prevalence 
of peripheral artery disease was 20.66%.
Conclusion: The prevalence of diabetic complications is significantly increased with patients age, duration, SBP, low-density lipoprotein, total 
cholesterol, and post-prandial blood sugar levels. Knowledge concerning the supervision of target blood pressure and lipid parameters is need further 
than the glycemic manage among diabetes patients type two.
Keywords: Glycosylated hemoglobin, Fasting blood sugar, Post-prandial blood sugar.
INTRODUCTION
Efficient supervision of diabetes needs continued glycemic control 
over several days to lesser the possibility of micro- and macro-vascular 
problems of diabetes. The UK prospective diabetes study established 
to each 1% decrease in glycosylated hemoglobin (HbA1c) be linked by 
means of a 37% reduction in micro- and macro-vascular complications 
and a 14% decline in myocardial infarction [1]. Although intensive 
glycemic control lowers the frequency and development of microvascular 
complications, the morbidity associated with these complications is 
still increasing [2]. Nowadays, more concentration has been given to the 
managing of large blood vessel problems, for example, cerebrovascular 
accident and acute coronary syndromes. It is finely recognized that 
blood vessel complication within a specified tissue can be frequently 
accompany by confirmation of pathology in other vascular territories. 
A linear association among small blood vessel complications and length 
of illness can be recognized by the authors where they acknowledged 
the occurrence of microvasculopathy across various age groups in their 
study in 25–40% of diabetic patients aged >25 years with a duration 
of diabetes was above 5 years [3]. One of the important risk factors for 
diabetes is obesity, so far very few research work focusing on obesity as 
one of the risk factor across India [4]. Even though the patients having 
reduced overweight and body mass index (BMI) rates, the prevalence 
of diabetes was highest in India when compared to western countries 
signifying that diabetes might arise on many Indian people with lower 
BMI comparison with Europeans [4,5]. As a result, comparatively, 
adult with low body weight and lower BMI could be next to equivalent 
danger when persons who are overweight [6]. Moreover, Indians are 
hereditarily disposed to the progress of coronary heart disease due to 
dyslipidemia, and high-density lipoprotein (HDL) levels are low [7]. 
Timely remedial actions, goal to become stable blood glucose levels 
along with a decline in low-density lipoprotein and triglycerides as 
well as to boost HDL, considerably decrease adverse events on heart 
and death of type two diabetes [8]. Our study was designed to check 
the desired results attained in the supervision of diabetes mellitus 
type two and to learn the occurrence of complications in South Indian 
Population.
METHODS
A prospective study of type 2 diabetic patients was carried out in a private 
diabetic center, Chennai with 300 outpatients, the study was approved 
by the Institutional Ethics Committee (Ref: IEC/PHD/2015/2016/01), 
Vels Institute of Science, Technology and Advanced Studies (VISTAS) 
and conducted based on the inclusion and exclusion criteria. Inclusion 
criteria are based on type 2 diabetes either fasting blood sugar (FBS) 
>125 mg/dl or post-prandial blood sugar (PPBS) >200 mg/dl, a patient 
who agreed to check for complications of diabetes 2 mellitus, patients 
with regular follow-up and treatment. We excluded the patients, those 
who are present with type 1 diabetes mellitus, diabetic pregnant women, 
people are not willing to participate, patients who were not under 
regular treatment. All demographic and clinical data of patients such as 
FBS, PPBS, HbA1c, low-density lipoprotein (LDL), very LDL, HDL, and 
total cholesterol were collected and documented in a suitably designed 
case extraction form. Suggestion from the eye specialist was obtained to 
check the condition of retinopathy through using fundoscopy. Vibration 
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perception test carries out to identify the presence of neuropathy. 
Renal function tests, particularly, microalbuminuria were performed to 
identify the presence of nephropathy. Peripheral arterial disease was 
identified by checking the ankle brachial index. The guidelines framed 
by Indian Council of Medical Research in the year 2005 in connection 
through the World Health Organization be used to categorize the 
targets achieved in the patients (Table 1).
Statistical analysis
Statistical analysis was carried out using Microsoft Excel and GraphPad 
Prism. Average and standard deviation were calculated for biochemical 
parameters. Comparison of means of every parameter of the group with 
and without complications was studied.
RESULTS
A prospective study was carried out with 300 outpatients in a 
diabetes center. The average age of 300 participants was calculated 
to be 55.006±13.04. The average BMI was 27.10±12.81kg/m2. The 
average duration of diabetes was 10.48±7.53. The average of systolic 
and diastolic blood pressure (SBP and DBP) was 137±20.88 and 
79.95±11.81. The mean glycated A1c, FBS, PPBS, low and HDL, and 
triglyceride, and total cholesterol were found to be 8.5±3.99, 148.85± 
55.64 mg/dl, 200.98±72.63 mg/dl, 88.06±19.46 mg/dl, 36.20± 
8.27 mg/dl, 141.22±60.15 mg/dl, and 144.45±29.03 mg/dl, respectively. 
Among the microvascular complications; neuropathy, nephropathy, and 
retinopathy were documented in 8.33%, 23.66% (Table 2), and 17.33% 
(Table 3) of patients, respectively. The prevalence of peripheral artery 
disease was 20.66% (Table 3).
In type 2 diabetes mellitus, an average of every clinical parameter in 
the group with complication was compared to nil complication was 
studied. Table 2 represents the prevalence of with neuropathy and 
without correlates statistically significant with PPBS and HDL values, 
the prevalence of with nephropathy and without nephropathy highly 
significant with SBP, FBS, PPBS, total cholesterol, and LDL. Table 3 
represents the prevalence of with retinopathy or without retinopathy 
highly significantly with age, SBP, FBS, PPBS, total cholesterol, and LDL 
but the prevalence of peripheral arterial disease not significant with 
any of the parameters. Table 4 represents the achievements of targets 
of various clinical and biochemical parameters according to the ICMR 
2005 guidelines. All the patients were interested in controlling body 
weight and blood pressure control but the majority of the patients not 
achieved the targets of controlling blood sugar levels.
Table 1: Targets in the management of type 2 diabetes 







FBS (mg/dl) 80–110 111–125 >125
PPBS (mg/dl) 120–140 140–180 >180
Glycated hemoglobin (%) <7% 7-8% >8%
Blood pressure (mmHg) <130/80 <140/90 >140/90
BMI (kg/m2) 20–23 Nil Nil
Total cholesterol (mg/dl) <180 Nil Nil
LDL (mg/dl) <100 Nil Nil
HDL (mg/dl) >45 Nil Nil
Triglycerides (mg/dl) <150 Nil Nil
HDL: High-density lipoprotein, FBS: Fasting blood sugar, PPBS: Post-prandial 
blood sugar, BMI: Body mass index, LDL: Low-density lipoprotein
Table 2: Comparison of means of different parameters in the presence or absence group of neuropathy and nephropathy
Complications parameters Neuropathy Nephropathy
Present n=52 Absent n=248 p value Present n=71 Absent n=229 p value 
Age (years) 57.08±14.39 54.82±12.93 0.40 57.34±12.68 54.28±13.10 0.084
Duration (years) 9.64±6.36 10.56±7.63 0.55 11.58±8.10 10.14±7.33 0.159
SBP (mmHg) 144.52±18.10 136.32±21.01 0.06 144.90±18.19 134.55±21.09 0.0002**
DBP (mmHg) 82.76±8.72 79.69±12.04 0.21 81.65±14.41 79.42±10.87 0.165 
BMI 27.10±3.55 27.04±4.89 0.95 27.36±5.27 27.82±14.37 0.79 
HbA1c (%) 8.96±2.23 8.46±4.12 0.55 8.98±2.41 8.35±4.36 0.245 
FBS (mg/dl) 164.48±61.89 147.42±54.94 0.14 162.53±63.11 144.60±52.55 0.01* 
PPBS (mg/dl) 229.06±72.49 198.40±72.09 0.04 224.28±89.10 193.47±65.19 0.001** 
Total cholesterol (mg/dl) 153.08±25.53 143.67±29.25 0.12 153.51±32.83 141.65±27.22 0.0025* 
LDL (mg/dl) 89.64±17.69 82.46±19.54 0.077 88.90±25.03 81.25±17.04 0.003** 
HDL (mg/dl) 32.50±9.83 36.43±8.11 0.02*3 36.07±7.12 36.25±8.62 0.87 
Triglycerides (mg/dl) 161.64±65.95 138.60±55.80 0.09 149.61±56.89 139.01±60.42 0.191
HDL: High-density lipoprotein, FBS: Fasting blood sugar, PPBS: Post-prandial blood sugar, BMI: Body mass index, LDL: Low-density lipoprotein, SBP: Systolic blood 
pressure, DBP: Diastolic blood pressure
Table 3: Comparison of means of different parameters in the presence or absence group of retinopathy and peripheral arterial disease
Complications parameters Retinopathy Peripheral arterial disease 
Present n=52 Absent n=248 p value Present n=62 Absent n=238 p value
Age (years) 65.58±11.8 52.79±12.19 0.0001** 52.20±13.52 54.95±12.94 0.893
Duration (years) 11.58±8.10 10.14±7.33 0.159 10.53±8.04 10.47±7.40 0.955
SBP (mmHg) 144.90±18.19 134.55±21.09 0.0002** 134.58±24.23 137.63±19.92 0.306 
DBP (mmHg) 81.65±14.41 79.42±10.87 0.165 81.35±9.66 79.58±12.30 0.294 
BMI 27.36±5.27 27.82±14.37 0.79 27.23±4.61 26.95±4.83 0.681 
HbA1c(%) 8.98±2.41 8.35±4.36 0.245 8.12±2.27 8.60±4.32 0.399 
FBS (mg/dl) 162.53±63.11 144.60±52.55 0.01* 141.46±40.83 150.77±58.81 0.241 
PPBS (mg/dl) 224.28±89.10 193.47±65.19 0.001** 190.82±49.64 203.63±77.39 0.216 
Total cholesterol (mg/dl) 153.51±32.83 141.65±27.22 0.0025** 141.14±27.41 145.31±29.43 0.314 
LDL (mg/dl) 88.90±25.03 81.25±17.04 0.003** 82.40±19.58 83.23±19.47 0.765 
HDL (mg/dl) 36.07±7.12 36.25±8.62 0.87 37.09±8.79 35.97±8.14 0.343 
Triglycerides (mg/dl) 149.61±56.89 139.01±60.42 0.191 133.35±41.27 141.58±59.10 0.302 
HDL: High-density lipoprotein, FBS: Fasting blood sugar, PPBS: Post-prandial blood sugar, BMI: Body mass index, LDL: Low-density lipoprotein, SBP: Systolic blood 
pressure, DBP: Diastolic blood pressure
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DISCUSSION
Our study was aimed to evaluate the diabetes treatment and to learn 
the occurrence of a problem in this hospital system. This current study 
indicates that the higher prevalence of diabetic complications such 
as neuropathy, nephropathy, and retinopathy was documented in 
8.33%, 23.66%, and 17.33% of patients, respectively. The prevalence 
of peripheral artery disease was 20.66%. A study conducted by 
Arambewela et al., in Sri Lanka microvascular complications such as 
retinopathy, nephropathy, and neuropathy reported as 26.1%, 50.8%, 
and 62.6% and macrovascular complications such as peripheral 
vascular disease reported as 4.2%. The results of our study were 
compared to Sri Lankan diabetes people, prevalence of complications 
was lower in our study [9]. The diabetes complications and control 
trial recognized <7% of glycated hemoglobin levels suitable for 
decreasing the possibility of blood vessel related problems and as well 
the gold standard of blood glucose control [10]. Glycated hemoglobin 
was greater than 8% in all the diabetic complications of our study. 
The similar study by Unnikrishnan et al. studied in 480 patients 
among personally reported type two diabetes (urban 254 and 226 
rural), the average levels of glycated hemoglobin were maximum 
of 9.1–2.3% in Chandigarh, followed by 8.2–2.0% in Tamil Nadu, 
8.2–2.4% in Jharkhand, and 8.0–2.1% in Maharashtra [11]. In our 
study, severity of retinopathy, nephropathy, and peripheral arterial 
disease was increased with the duration and increased HbA1c levels. 
The study conducted by Samantha et al., the severity of retinopathy 
and neuropathy was related to the longer duration of diabetes and 
high levels of glycosylated hemoglobin. The incidence of retinopathy 
was significantly increased with the duration of the diabetes mellitus, 
and it was associated with a poor glycemic control [12]. In our study, 
the values for FBS and PPBS were increased in patients with diabetic 
complications. The similar studies results reported that considerably 
higher levels of FBS, total cholesterol, triglycerides, and low-density 
lipoprotein achieved with patients of poor and worse control [13-15]. 
Another study by Haghighatpanah et al. reported PPBS had a closer 
association with HbA1c and better predictor for overall glycemic 
control [16].
CONCLUSION
The present work ensures the prevalence of complications and 
poor blood glucose control of type 2 diabetes mellitus considerably 
raised with patients age, duration, SBP, LDL, total cholesterol, and 
post-prandial blood sugar levels. Hence, the management of blood 
pressure, blood sugar levels, HbA1c, and lipid profile are necessary to 
avoid the life frightening problems such as the atherosclerotic heart. 
Awareness about the disease and education is necessary to prevent 
their progression.
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Table 4: Targets achieved in the management of important parameters of diabetes
Number of patients Parameter FBS PPBS HbA1C BMI LDL BP 
All patients Ideal 75 51 96 63 224 134 
Satisfactory 48 93 76 170 - 64 
Unsatisfactory 177 156 128 67 56 102 
HDL: High-density lipoprotein, FBS: Fasting blood sugar, PPBS: Post-prandial blood sugar, BMI: Body mass index, LDL: Low-density lipoprotein, SBP: Systolic blood 
pressure, DBP: Diastolic blood pressure
